Pharmacogenetics

Oct 29, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Pharmacogenetics

Predicted CYP2D6 metabolism phenotype Implications for codeine metabolism Therapeutic recommendations Ultrarapid metabolizer (UM) Increased formation of morphine following codeine administration, leading to higher risk of toxicity Avoid codeine use due…

read more

Neurodegenerative Disorders

Oct 29, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Neurodegenerative Disorders

Gene symbol Gene product Chromosomal location Key information Definitive disease-causing genes (causative mutations of early onset Alzheimer disease ) APP (AD1) Amyloid precursor protein 21q21.3 Autosomal dominant, 25 pathogenic mutations,…

read more

Molecular Pathology Laboratory Management

Oct 29, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Molecular Pathology Laboratory Management

Application Considerations Genetics Ethical issues (presymptomatic and prenatal testing) Consequences for family members Informed consent requirements Requirements for family-related information (ethnicity, pedigree, specimens) Time sensitivity (prenatal diagnosis) Complex risk-assessment calculations…

read more

Hepatitis B and C Viruses

Oct 29, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Hepatitis B and C Viruses

Characteristic Hepatitis B virus Hepatitis C virus Type of virus Hepadnavirus Hepacivirus Viral genome 3.2 kb, relaxed circular, partially double-stranded DNA 9.5 kb, positive-sense, single-stranded RNA Routes of transmission Parenteral…

read more

Urothelial Carcinoma

Oct 29, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Urothelial Carcinoma

Figure 34.1 Genetic pathways for urothelial carcinoma tumorigenesis. Noninvasive papillary tumors are characterized by early activating mutations of the FGFR3 gene, inactivating mutations or epigenetic alterations of the P16 gene,…

read more
Get Clinical Tree app for offline access